시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 특발성 폐섬유증 시장 : 약물 유형별, 투여 경로별, 유통 채널별, 지역별, 국가별 분석, 시장 인사이트, 예측
Global Idiopathic Pulmonary Fibrosis Market : Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast
상품코드 : 1300105
리서치사 : Azoth Analytics
발행일 : 2023년 07월
페이지 정보 : 영문 260 Pages
 라이선스 & 가격 (부가세 별도)
US $ 2,450 ￦ 3,359,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 2,950 ￦ 4,044,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 특발성 폐섬유증 시장 규모는 2022년 43억 9,000만 달러에서 2029년 말에는 106억 4,000만 달러에 달할 것으로 예상되며, 예측 기간인 2024년부터 2029년까지 연평균 46.3%의 성장률을 보일 것으로 예상됩니다.

이 보고서는 세계 특발성 폐섬유증 시장에 대해 조사했으며, 시장 규모와 예측, 지역 및 부문 분석, 주요 동향과 기회 등의 정보를 전해드립니다.

목차

제1장 시장 배경

제2장 전략적 추천사항

제3장 세계의 특발성 폐섬유증 시장 : 실적과 예측

제4장 세계의 특발성 폐섬유증 시장, 지역 분석

제5장 아메리카의 특발성 폐섬유증 시장 : 실적과 예측(2018-2028년)

제6장 유럽의 특발성 폐섬유증 시장 : 실적과 예측(2018-2028년)

제7장 아시아태평양의 특발성 폐섬유증 시장 : 실적과 예측(2018-2028년)

제8장 중동 및 아프리카의 특발성 폐섬유증 시장 : 실적과 예측(2018-2028년)

제9장 시장 역학

제10장 업계 생태계 분석

제11장 경쟁 포지셔닝

ksm
영문 목차

영문목차

Executive Summary

Azoth Analytics has released a research report titled "Idiopathic Pulmonary Fibrosis Market (2023 Edition)" which provides a complete analysis of the global Idiopathic Pulmonary Fibrosis industry in terms of market segmentation by Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel).

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 11 countries (United States, Canada, Mexico, United Kingdom, Germany, France, Italy, China, India, Japan, South Korea). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research study also looks at the market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

During the forecast period, 2024-2029, the Global Idiopathic Pulmonary Fibrosis market is expected to expand at a CAGR of 46.3%. The Global Idiopathic Pulmonary Fibrosis Market is expected to generate USD 10.64 billion by the end of 2029, up from USD 4.39 billion in 2022.

IPF is a life-threatening illness and is both progressive and incurable. Treatments can manage symptoms, limit disease progression, and improve quality of life. Pirfenidone and nintedanib are authorized IPF treatments that slow fibrosis. Severe instances may require lung transplants.

Although IPF is considered a rare disease, its incidence has increased over time. It is estimated that 13 to 20 people per 100,000 are affected globally. The prevalence is higher in older age categories, and the disease is diagnosed more frequently in people over 50. IPF affects both men and women, although men are slightly more susceptible. Ongoing research and clinical trials are investigating novel treatments and potential IPF therapies. Among these are antifibrotic agents, immunomodulatory drugs, and other novel therapeutic approaches that target different pathways implicated in the fibrotic process.

IPF patients need medical follow-ups. Work with interstitial lung disease specialists to create a specific treatment plan and support methods. IPF is characterized by a persistent dry cough, shortness of breath (especially during physical activity), exhaustion, and chest pain. These symptoms typically develop and worsen over time.

Scope of the Report:

Table of Contents

1. Market Background

2. Strategic Recommendations

3. Global Idiopathic Pulmonary Fibrosis Market: Historic and Forecast

4. Global Idiopathic Pulmonary Fibrosis Market, Regional Analysis

5. Americas Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

6. Europe Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

7. Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

8. Middle-East & Africa Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)

9. Market Dynamics

10. Industry Ecosystem Analysis

11. Competitive Positioning

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기